Derect lymphocyte-mediated cytotoxicity as an assay of presensitisation

Why do we reject grafts?

Heart disease (Hagerstown, Md.)·2002

Protection of macaques against vaginal transmission of a pathogenic HIV-1/SIV chimeric virus by passive infusion of neutralizing antibodies.

Nature medicine·2000

Cellular and humoral mechanisms of vascularized allograft rejection induced by indirect recognition of donor MHC allopeptides.

Transplantation·1999

Inhibition of allorecognition by a human class II MHC-derived peptide through the induction of apoptosis.

The Journal of clinical investigation·1999

Late blockade of T cell costimulation interrupts progression of experimental chronic allograft rejection.

The Journal of clinical investigation·1998

Mechanisms of indirect allorecognition: characterization of MHC class II allopeptide-specific T helper cell clones from animals undergoing acute allograft rejection.

Transplantation·1998

Immunogenicity of fractional one-fifth and one-half doses of 17DD yellow fever vaccine compared with full dose in children aged 9-23 months in Uganda: a phase 4, single-blind, randomised clinical trial.

Lancet (London, England)·2026

Efficacy and safety of mitapivat in adults with transfusion-dependent α-thalassaemia or β-thalassaemia (ENERGIZE-T): a double-blind, randomised, multicentre, placebo-controlled, phase 3 trial.

Lancet (London, England)·2026

Perioperative durvalumab plus fluorouracil, leucovorin, oxaliplatin, and docetaxel for resectable gastric and gastro-oesophageal junction adenocarcinoma (MATTERHORN): final results of overall survival and event-free survival by pathological response in a global, randomised, double-blind, placebo-controlled, multicentre, phase 3 trial.

Lancet (London, England)·2026

Wildfire smoke and health: current evidence, mechanisms, and future challenges.

Lancet (London, England)·2026

Adverse events, quality of life, and work impairment in patients with chronic myeloid leukemia (CML)-a survey of first- and second-line tyrosine kinase inhibitor (TKI) intolerance in the US.

Leukemia & lymphoma·2026

Belatacept and the Risk of Cytomegalovirus, BK Polyomavirus, and Epstein-Barr Virus Post-transplant Lymphoproliferative Disease After Kidney Transplantation: A Meta-Analysis and Systematic Review.

Journal of transplantation·2026

Early Recognition of Neuroleptic Malignant Syndrome Without Hyperthermia: A Narrative Review.

Cureus·2026

The Great Mimicker: Variable Presentations of Xanthogranulomatous Salpingo-Oophoritis in a Case Series of Seven Patients From a Rural Tertiary Care Center.

Cureus·2026

Decision Fatigue and Associated Factors Among Patients with Hematologic Malignancies: Implications for Patient-Centered Decision Support.

Patient preference and adherence·2026

Oncocytic and Follicular Thyroid Carcinomas Arising in Hashimoto's Thyroiditis: Two Rare Cases Highlighting an Unusual Association.

Cureus·2026

Related Experiment Videos

Derect lymphocyte-mediated cytotoxicity as an assay of presensitisation

Related Concept Videos

Why do we reject grafts?

Protection of macaques against vaginal transmission of a pathogenic HIV-1/SIV chimeric virus by passive infusion of neutralizing antibodies.

Cellular and humoral mechanisms of vascularized allograft rejection induced by indirect recognition of donor MHC allopeptides.

Inhibition of allorecognition by a human class II MHC-derived peptide through the induction of apoptosis.

Late blockade of T cell costimulation interrupts progression of experimental chronic allograft rejection.

Mechanisms of indirect allorecognition: characterization of MHC class II allopeptide-specific T helper cell clones from animals undergoing acute allograft rejection.

Immunogenicity of fractional one-fifth and one-half doses of 17DD yellow fever vaccine compared with full dose in children aged 9-23 months in Uganda: a phase 4, single-blind, randomised clinical trial.

Efficacy and safety of mitapivat in adults with transfusion-dependent α-thalassaemia or β-thalassaemia (ENERGIZE-T): a double-blind, randomised, multicentre, placebo-controlled, phase 3 trial.

Wildfire smoke and health: current evidence, mechanisms, and future challenges.

Adverse events, quality of life, and work impairment in patients with chronic myeloid leukemia (CML)-a survey of first- and second-line tyrosine kinase inhibitor (TKI) intolerance in the US.

Belatacept and the Risk of Cytomegalovirus, BK Polyomavirus, and Epstein-Barr Virus Post-transplant Lymphoproliferative Disease After Kidney Transplantation: A Meta-Analysis and Systematic Review.

Early Recognition of Neuroleptic Malignant Syndrome Without Hyperthermia: A Narrative Review.

The Great Mimicker: Variable Presentations of Xanthogranulomatous Salpingo-Oophoritis in a Case Series of Seven Patients From a Rural Tertiary Care Center.

Decision Fatigue and Associated Factors Among Patients with Hematologic Malignancies: Implications for Patient-Centered Decision Support.

Oncocytic and Follicular Thyroid Carcinomas Arising in Hashimoto's Thyroiditis: Two Rare Cases Highlighting an Unusual Association.

Related Experiment Videos

Derect lymphocyte-mediated cytotoxicity as an assay of presensitisation

Related Concept Videos

Related Articles